7Baggers
The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.

OKYO Pharma
(NASDAQ:OKYO) 

OKYO stock logo

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. It is developing OK-101 for the treatment of dry eye disease; and OK-201, a bovine adrenal medulla, lipidated-...

Founded: 2007
IPO Price: $4 (May 17, 2022)
Full Time Employees: 6
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends
OKYO Pharma Days Payable Outstanding ttm (DPO)
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 079.49158.99238.48317.98397.47476.96556.46Thousand
OKYO Pharma Op Cashflow Per Share ttm
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -91.08-78.07-65.06-52.05-39.03-26.02-13.010
OKYO Pharma Free Cashflow Per Share ttm
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -91.11-78.09-65.08-52.06-39.05-26.03-13.020
OKYO Pharma Cash Per Share ttm
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 025.2750.5475.81101.08126.35151.62176.89
OKYO Pharma (GAAP) P/E ratio ttm
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -371.68-318.58-265.48-212.39-159.29-106.19-53.10
OKYO Pharma P/B ratio ttm
202303 202304 202305 202306 202307 202308 202309 202310 202311 202312 202401 202402 202403 202404 -16.58-12.99-9.39-5.8-2.21.44.998.59
No extra charts and metrics for this ticker.